Form 4: Allovir CEO Sells Shares to Cover Tax Obligations After RSU Vesting

Allovir CEO Diana Brainard sold 8,706 shares of common stock at an average price of $0.5485 to cover tax obligations related to the vesting of restricted stock units.

Summary

• Allovir's CEO, Diana Brainard, sold 8,706 shares of common stock on November 19, 2024.
• The sale was executed at a weighted average price of $0.5485 per share.
• The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
• The sales were automatic and not at the discretion of the CEO.
• Following the transaction, Diana Brainard beneficially owns 723,363 shares of Allovir common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and does not indicate any positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the industry.
• The sale price of $0.5485 is within the range of recent trading activity for Allovir stock.
• The number of shares sold is relatively small compared to the total shares held by the CEO.

Stakeholder Impact

• The sale of shares by the CEO may have a minor impact on the stock price, but it is not expected to be significant.
• The transaction does not impact the company's operations or financial health.

Key Dates

Keywords

Allovir, Diana Brainard, stock sale, restricted stock units, tax obligations, insider trading, Form 4